Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017 (2017), Article ID 7938216, 9 pages
https://doi.org/10.1155/2017/7938216
Research Article

Metabolomic Signature of Coronary Artery Disease in Type 2 Diabetes Mellitus

1Herz- und Diabeteszentrum NRW, Ruhr-Universitaet Bochum, Diabeteszentrum, 32545 Bad Oeynhausen, Germany
2Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, 85764 Neuherberg, Germany
3Institute of Epidemiology II, Helmholtz Zentrum München, 85764 Neuherberg, Germany
4Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany
5Institute of Experimental Genetics, Life and Food Science Center Weihenstephan, Technische Universität München, 85354 Freising, Germany
6German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany

Correspondence should be addressed to Bernd Stratmann; ed.wrn-zdh@nnamtartsb

Received 9 August 2016; Revised 1 December 2016; Accepted 20 December 2016; Published 1 March 2017

Academic Editor: Qian Li

Copyright © 2017 Bernd Stratmann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Lillioja, D. M. Mott, M. Spraul et al., “Insulin-resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes-mellitus—prospective studies of Pima-Indians,” New England Journal of Medicine, vol. 329, no. 27, pp. 1988–1992, 1993. View at Publisher · View at Google Scholar
  2. E. Ferrannini, “Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects,” Endocrine Reviews, vol. 19, no. 4, pp. 477–490, 1998. View at Publisher · View at Google Scholar
  3. E. Selvin, S. Marinopoulos, G. Berkenblit et al., “Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus,” Annals of Internal Medicine, vol. 141, no. 6, pp. 421–431, 2004. View at Publisher · View at Google Scholar
  4. B. Stratmann and D. Tschoepe, “Sweet heart—contributions of metabolism in the development of heart failure in diabetes mellitus,” Experimental and Clinical Endocrinology & Diabetes, vol. 116, Supplement 1, pp. S40–S45, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Nichols, N. Townsend, P. Scarborough, and M. Rayner, “Cardiovascular disease in Europe 2014: epidemiological update,” European Heart Journal, vol. 35, no. 42, pp. 2929–2929, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso, “Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction,” New England Journal of Medicine, vol. 339, no. 4, pp. 229–234, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. Beckman, M. A. Creager, and P. Libby, “Diabetes and atherosclerosis: epidemiology, pathophysiology, and management,” JAMA, vol. 287, no. 19, pp. 2570–2581, 2002. View at Publisher · View at Google Scholar
  8. C. Iribarren, A. J. Karter, A. S. Go, and J. V. Selby, “Glycemic control and heart failure among adult patients with diabetes,” Circulation, vol. 103, no. 22, pp. 2668–2673, 2001. View at Publisher · View at Google Scholar
  9. S. H. Shah, J. R. Bain, M. J. Muehlbauer et al., “Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events,” Circulation-Cardiovascular Genetics, vol. 3, no. 2, pp. 207–214, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Würtz, J. R. Raiko, C. G. Magnussen et al., “High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis,” European Heart Journal, vol. 33, no. 18, pp. 2307–2316, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Orasanu and J. Plutzky, “The pathologic continuum of diabetic vascular disease,” Journal of the American College of Cardiology, vol. 53, no. 5, pp. S35–S42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Ekroos, M. Janis, K. Tarasov, R. Hurme, and R. Laaksonen, “Lipidomics: a tool for studies of atherosclerosis,” Current Atherosclerosis Reports, vol. 12, no. 4, pp. 273–281, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Hornemann and T. S. Worgall, “Sphingolipids and atherosclerosis,” Atherosclerosis, vol. 226, no. 1, pp. 16–28, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Suhre, C. Meisinger, A. Doring et al., “Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting,” PloS One, vol. 5, no. 11, Article ID e13953, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. L. D. Roberts and R. E. Gerszten, “Toward new biomarkers of cardiometabolic diseases,” Cell Metabolism, vol. 18, no. 1, pp. 43–50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. T. J. Wang, M. G. Larson, R. S. Vasan et al., “Metabolite profiles and the risk of developing diabetes,” Nature Medicine, vol. 17, no. 4, pp. 448–453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. H. Shah, W. E. Kraus, and C. B. Newgard, “Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function,” Circulation, vol. 126, no. 9, pp. 1110–1120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Floegel, N. Stefan, Z. H. Yu et al., “Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach,” Diabetes, vol. 62, no. 2, pp. 639–648, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Stegemann, R. Pechlaner, P. Willeit et al., “Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study,” Circulation, vol. 129, no. 18, pp. 1821–1831, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Psychogios, D. D. Hau, J. Peng et al., “The human serum metabolome,” PloS One, vol. 6, no. 2, Article ID e16957, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. H. Zhang, H. Sun, P. Wang, Y. Han, and X. J. Wang, “Recent and potential developments of biofluid analyses in metabolomics,” Journal of Proteomics, vol. 75, no. 4, pp. 1079–1088, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. G. D. Lewis, A. Asnani, and R. E. Gerszten, “Application of metabolomics to cardiovascular biomarker and pathway discovery,” Journal of the American College of Cardiology, vol. 52, no. 2, pp. 117–123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Wang-Sattler, Z. H. Yu, C. Herder et al., “Novel biomarkers for pre-diabetes identified by metabolomics,” Molecular Systems Biology, vol. 8, p. 615, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. H. Shah, J. L. Sun, R. D. Stevens et al., “Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease,” American Heart Journal, vol. 163, no. 5, Article ID e841, pp. 844–850, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. P. R. Cullis and M. J. Hope, “Physical properties and functional roles of lipids in membranes,” in Biochemistry of lipids and membranes, ed, D. E. Vance, Ed., pp. 25–72, Benjamin Cummings Publishing, Menlo Park, CA, 1985. View at Google Scholar
  26. J. H. Exton, “Signaling through phosphatidylcholine breakdown,” Journal of Biological Chemistry, vol. 265, no. 1, pp. 1–4, 1990. View at Google Scholar
  27. X. C. Jiang, F. Paultre, T. A. Pearson et al., “Plasma sphingomyelin level as a risk factor for coronary artery disease,” Arteriosclerosis Thrombosis and Vascular Biology, vol. 20, no. 12, pp. 2614–2618, 2000. View at Publisher · View at Google Scholar
  28. H. L. Lin, J. Zhang, and P. Gao, “Silent myocardial ischemia is associated with altered plasma phospholipids,” Journal of Clinical Laboratory Analysis, vol. 23, no. 1, pp. 45–50, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Yeboah, C. McNamara, X. C. Jiang et al., “Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population multi-ethnic study of atherosclerosis,” Arteriosclerosis Thrombosis and Vascular Biology, vol. 30, no. 3, pp. 628–633, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Sutter, R. Klingenberg, A. Othman et al., “Decreased phosphatidylcholine plasmalogens—a putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction,” Atherosclerosis, vol. 246, pp. 130–140, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. C. T. Ferrara, P. Wang, E. C. Neto et al., “Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling,” PLoS Genetics, vol. 4, no. 3, Article ID e1000034, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. S. H. Shah, E. R. Hauser, J. R. Bain et al., “High heritability of metabolomic profiles in families burdened with premature cardiovascular disease,” Molecular Systems Biology, vol. 5, p. 258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Illig, C. Gieger, G. Zhai et al., “A genome-wide perspective of genetic variation in human metabolism,” Nature Genetics, vol. 42, no. 2, pp. 137–141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Romisch-Margl, C. Prehn, R. Bogumil, C. Röhring, K. Suhre, and J. Adamski, “Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics,” Metabolomics, vol. 8, no. 1, pp. 133–142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Mittelstrass, J. S. Ried, Z. H. Yu et al., “Discovery of sexual dimorphisms in metabolic and genetic biomarkers,” PLoS Genetics, vol. 7, no. 8, Article ID e1002215, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. H. Yu, G. J. Zhai, P. Singmann et al., “Human serum metabolic profiles are age dependent,” Aging Cell, vol. 11, no. 6, pp. 960–967, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Lorber, L. E. Wangen, and B. R. Kowalski, “A theoretical foundation for the PLS algorithm,” Journal of Chemometrics, vol. 1, no. 1, pp. 19–31, 1987. View at Publisher · View at Google Scholar
  38. P. Rein, A. Vonbank, C. H. Saely et al., “Relation of albuminuria to angiographically determined coronary arterial narrowing in patients with and without type 2 diabetes mellitus and stable or suspected coronary artery disease,” The American Journal of Cardiology, vol. 107, no. 8, pp. 1144–1148, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Sing, O. Sander, N. Beerenwinkel, and T. Lengauer, “ROCR: visualizing classifier performance in R,” Bioinformatics, vol. 21, no. 20, pp. 3940–3941, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. P. J. Meikle, G. Wong, D. Tsorotes et al., “Plasma lipidomic analysis of stable and unstable coronary artery disease,” Arteriosclerosis Thrombosis and Vascular Biology, vol. 31, no. 11, pp. 2723–2732, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Coleman, “Membrane-bound enzymes and membrane ultrastructure,” Biochimica et Biophysica Acta, vol. 300, no. 1, pp. 1–30, 1973. View at Publisher · View at Google Scholar · View at Scopus
  42. W. Zheng, J. Kollmeyer, H. Symolon et al., “Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy,” Biochimica et Biophysica Acta-Biomembranes, vol. 1758, no. 12, pp. 1864–1884, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Wallner and G. Schmitz, “Plasmalogens the neglected regulatory and scavenging lipid species,” Chemistry and Physics of Lipids, vol. 164, no. 6, pp. 573–589, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. N. S. Dhalla, A. Ziegelhoffer, and J. A. C. Harrow, “Regulatory role of membrane systems in heart function,” Canadian Journal of Physiology and Pharmacology, vol. 55, no. 6, pp. 1211–1234, 1977. View at Publisher · View at Google Scholar
  45. A. M. Hodge, D. R. English, K. O'Dea et al., “Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid,” American Journal of Clinical Nutrition, vol. 86, no. 1, pp. 189–197, 2007. View at Google Scholar
  46. G. Malerba, L. Schaeffer, L. Xumerle et al., “SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease,” Lipids, vol. 43, no. 4, pp. 289–299, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. D. E. Vance, “Phospholipid metabolism in eucaryotes,” in Biochemistry of lipids and membranes ed, D. E. Vance, Ed., pp. 25–72, Benjamin Cummings Publishing, Menlo Park, CA, 1985. View at Google Scholar
  48. L. K. Cole, J. E. Vance, and D. E. Vance, “Phosphatidylcholine biosynthesis and lipoprotein metabolism,” Biochimica et Biophysica Acta, vol. 1821, no. 5, pp. 754–761, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. V. Bodi, J. Sanchis, J. M. Morales et al., “Metabolomic profile of human myocardial ischemia by nuclear magnetic resonance spectroscopy of peripheral blood serum: a translational study based on transient coronary occlusion models,” Journal of the American College of Cardiology, vol. 59, no. 18, pp. 1629–1641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Reiss, K. Beyer, and B. Engelmann, “Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro,” Biochemical Journal, vol. 323, no. Pt 3, pp. 807–814, 1997. View at Publisher · View at Google Scholar
  51. W. J. Visek, “An update of concepts of essential amino-acids,” Annual Review of Nutrition, vol. 4, pp. 137–155, 1984. View at Publisher · View at Google Scholar
  52. J. Endo, M. Sano, T. Katayama et al., “Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heart,” Circulation Research, vol. 105, no. 11, pp. 1118–1127, 2009. View at Publisher · View at Google Scholar · View at Scopus